Skip to main content
Premium Trial:

Request an Annual Quote

Akesogen, London Genetics Team on Pharmacogenetic Services

NEW YORK (GenomeWeb News) – Akesogen, a Norcross, Ga.-based genomic and biorepository services firm, and London Genetics International today announced that they will collaborate on offering pharmacogentic services to the biopharmaceutical industry.

Among the services provided by the firms will be biomarker and assay development. Financial and other terms were not disclosed.

"Our expertise in pharmacogenetic strategy development combined with a professional genomics services company that operates to CLIA standards will make this strategic alliance beneficial to both companies as it will increase our scope of possible services into the Americas with highly qualified and service oriented scientists," Elizabeth Foot, VP of personalised medicine and nutrition for London Genetics, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more